ArticleAmerican journal of preventive cardiology2025
Coronary artery calcium burden across the pooled cohort equation versus the American Heart Association PREVENT risk calculator.
Article in American journal of preventive cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- PREVENT vs PCE thresholds for coronary artery calcium referral: Detection-optimized strategies in ELSA-Brasil.American journal of preventive cardiology · 2026Article
- As the picture gets prettier the bar must rise higher.American journal of preventive cardiology · 2026Article
- AJPC 2025 in review: A year of growth & clearer mandate for actionable prevention.American journal of preventive cardiology · 2026Article
- Lowering barriers Not the bar: Redefining the role of American Journal of Preventive Cardiology in the next era.American journal of preventive cardiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Pooled Cohort Equation (PCE) and the Predicting Risk of cardiovascular disease EVENTs (PREVENT) calculator assess atherosclerotic cardiovascular disease (ASCVD) risk. Coronary artery calcium (CAC) scoring enhances ASCVD risk stratification beyond traditional risk factors, but CAC burden across PCE versus PREVENT risk groups remains unclear. This study evaluates the distribution of CAC burden across PCE and PREVENT risk groups. Methods: A retrospective cohort study was conducted involving 7610 asymptomatic patients who underwent clinically indicated CAC scoring between 2010 and 2023. Ten-year ASCVD risk was calculated using PCE and PREVENT (low<5, borderline-intermediate 5-19, high≥20 %). CAC scores (0, 1-99, 100-299, ≥300) were compared across risk groups using Kendall Tau tests. Results: The mean age was 57±9 years; 41 % of patients were women and 11 % identified as Black. PCE and PREVENT classified 52.5 % and 72.6 % as low-risk, 41 % and 27.1 % as borderline-intermediate risk, and 6.5 % and 3.7 % as high-risk, respectively. Higher PCE/PREVENT risk groups had increased median CAC Conclusions: A significant number of patients had non-zero CAC in low-risk stratification groups for both PREVENT and PCE. CAC distribution was heterogeneous in the borderline-intermediate groups for both PREVENT and PCE. These results emphasize the significance of CAC in further stratifying risk beyond the PCE and PREVENT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.